Evgen Pharma (GB:TCF) has released an update.
TheraCryf plc, a clinical-stage drug development company, has announced the sudden passing of its Chair, Dr. Sue Foden. Dr. Foden was a pivotal figure in the company, serving since 2015 and contributing significantly to its focus on oncology and neuropsychiatry. The company plans to appoint a new non-executive director soon to continue its innovative work in the biotech sector.
For further insights into GB:TCF stock, check out TipRanks’ Stock Analysis page.
